Рентгеноэндоваскулярные технологии в лечении больных со злокачественными опухолями печени и поджелудочной железы
Диссертация
Единственным методом радикального лечения злокачественных опухолей печени остается оперативное вмешательство, позволяющее добиться длительной выживаемости при первичном и метастатическом раке печени. Однако, неудовлетворительная функция печени (>75% пациентов имеют хроническое заболевание печени), билобарное распространение процесса, внепеченочное метастазирование при гепатоцеллюлярном раке (ГЦР… Читать ещё >
Список литературы
- Абгарян М.Г. Диагностика и лечение больных раком поджелудочной железы с инвазией магистральных сосудов, Дисс. канд. мед. наук, М-2005.
- Аксель Е.М., Давыдов М. И., Ушакова Т. И. Злокачественные новообразования желудочно-кишечного тракта: основные статистические показатели и тенденции, Современная онкология, ТЗ, № 4, 2001.
- Блохин Н.Н., Итин А. Б., Клименков А. А. Рак поджелудочной железы и внепеченочных желчных путей.// М., 1982. — 272 с.
- Бредер В.В. Лекарственное лечение первичного рака печени. Материалы VII Российской онкологической конференции, М., 2003: 165−168.
- Гарин A.M., Базин И. С. Злокачественные опухоли пищеварительной системы. М., 2003. — 256 с.
- Горбунова В.А., Шатихин В. А. Внутрипеченочная артериальная инфузионная химиотерапия при первичном и метастатическом раке печени. Сов. медицина, 1990−12:66−68.
- Горбунова В.А., Орел Н. Ф., Егоров Г. Н., Кузминов А. Е. Высокодифференцированные нейроэндокринные опухоли (карциноиды) и нейроэндокринные опухоли поджелудочной железы. Современный взгляд на проблему. М., 2007, 104 с.
- Гранов Д.А., Таразов П.Г."Рентгеноэндоваскулярные вмешательства в лечении злокачественных опухолей печени", Санкт-Петербург, 2002.
- Гуртовая И.Б. Клиническая оценка эффективности химиоэмболизации у больных злокачественными новообразованиями печени Дисс. канд. мед. наук, М-1999.
- Давыдов М.И., Аксель Е. М. Злокачественные новообразования в России и странах СНГ в 2000 г. М., 2000.- 281 с.
- П.Давыдов М. И., Аксель Е. М. Статистика злокачественных новообразований в России и странах СНГ в 2005 г. Вестник РОНЦ им. Н. Н. Блохина РАМН, т 18, № 2 (прил. 1) 2007.
- Долгушин Б.И., Кучинский Г.А, Шатихин В. А. и др. Химиоэмболизация при карциноиде поджелудочной железы с метастазами в печень. Сов. медицина, 1991−4:90−91.
- Долгушин Б.И., Кучинский Г.А, Рощин Е. М. и др., Чрескатетерная артериальная химиоэмболизация неоперабельного гепатоцеллюлярного рака. Медицинская визуализация, 2007−5: с. 68−75.
- Егоров Г. Н., Рощин Е. М. Регионарная химиотерапия при метастазах в печень колоректального рака. В кн. «Новое в терапии колоректального рака», М., 2001, с.58−62.
- Имянитов Е.Н. Эпидемиология и биология нейроэндокринных опухолей, Практическая онкология, 2005-Т5, № 4: с. 202−205.
- Комов Д.В., Рощин Е. М., Гуртовая И. Б., «Лекарственное лечение первичного и метастатического рака печени», Москва 2002.
- Комов Д.В., Рощин Е. М., Хайленко В. А. и др. Возможности регионарной химиотерапии у больных с метастазами рака молочной железы в печень, Маммология, 1997, № 3, с. 41−45.
- Комов Д.В., Рощин Е. М., Кучинский Г. А. и др. Итоги 1 фазы клинических испытаний фетального альфа-фетопротеина человека как составной части препарата DDS-DEA у больных со злокачественными новообразованиями Вестник ОНЦ АМН России, 1997−3, с. 41−43.
- Комов Д.В., Рощин Е. М., Кучинский Г. А. и др. Итоги первой фазыклинических исследований комплекса доксорубицин-эстрон у больных со1злокачественными новообразованиями печени при химиоэмболизации с липиодолом, Вестник ОНЦ АМН России, 1997−4, с. 34−37.
- Комов Д.В., Рощин Е. М., Кучинский Г. А. и др. Итоги 1 фазы клинических испытаний комплекса доксорубицин-эстрон и фетального альфафетопротеина (DDS-DSA) человека при химиоэмболизации у больных раком печени, Вестник ОНЦ АМН России, 1998−2, с. 24−30.
- Котельников А.Г. Выбор метода лечения больных раком головки поджелудочной железы и периампулярной зоны, Дисс. докт. мед. наук, М-2001.
- Павловский А.В. Масляная химиоэмболизация артерий поджелудочной железы при местнораспространенном раке, Практическая онкология Т5, № 2, 2004, с. 108−114
- Павловский А.В. Обоснование селективной артериальной рентгеноконтрастной масляной химиоэмболизации в лечении рака поджелудочной железы (экспериментальное и клиническое исследования) Дисс. докт. мед. наук, С-П 2006.
- Патютко Ю. И., Хирургическое лечение злокачественных опухолей печени, Практическая медицина, М. 2005.
- Патютко Ю.И., Котельников А. Г., Абгарян М. Г. Современное хирургическое и комбинированное лечение больных экзокринным раком головки поджелудочной железы и органов периампулярной зоны, Практическая онкология 2004−5(2):94−107.
- Рощин Е.М. Возможности регионарной химиотерапии в лечении злокачественных опухолей печени, Дисс. докт. мед. наук М 1996.
- Рощин Е.М., Комов Д. В., Кучинский Г. А. и др. Химиоэмболизация в лечении больных первичным раком печени. Методические рекомендации, Н-Н, 1996.
- Стенина М.Б., Системная противоопухолевая терапия при раке органов билиопанкреатодуоденальной зоны Практическая онкология, Т. 5, № 2 -2004, с. 154−162.
- Таразов П.Г. Эмболизация печеночной артерии при нетипичных анатомических вариантах её строения у больных злокачественными опухолями печени, Вестник рентгенол. 1990−2:28−32.
- Таразов П.Г., Гранов Д. А., Поликарпов А. А., Методы интервенционной радиологиив лечении неколоректальных метастазов печени. Вестн. рентгенол., 1999−5:22−27.
- Таразов П.Г., Гранов Д. А., Поликарпов А. А. Чрескатетерная терапия метастазов рака желудка в печень. Вопросы онкологии, 2000−46(2):221−223.
- Таразов П.Г., Артериальная инфузия и эмболизация в лечении нерезектабельных злокачественных опухолей печени, Вестник РОНЦ им. Н. Н. Блохина РАМН, 2004−1-2:с. 115−120.
- Трапезников Н.Н., Аксель Е. М. — Заболеваемость злокачественными новообразованиями и смертность от них населения стран СНГ в 1998г. М., 2000, 270 с.
- Янкин А.В. Диагностика и лечения нейроэндокринных опухолей билиопанкреатодуоденальной зоны, Практическая онкология, 2004-Т5, № 2:145−153.
- Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, Kunstlinger F, Levi F, Bismuth F. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001−8:347−353.
- Ahlyren J.D. Epidemiology and risk factors in pancreatic cancer. Sem. in Oncol., 1996- 23:241−250.
- Aigner K.R., Muller H., Bassermann R. Intra-frterial chemotherapy with MMC, CDDR and 5-FU for nonresectable pancreatic cancer — a phase II study //Reg. CancerTreat.-1990.- Vol.3, Suppl. l-P. 1−6.
- Allema J., Reinders M., Van Gulic T. et al. Portal vein resection in patients undergoing pancreaticoduodenectomy for carcinoma of the pancreatic head region // Brit. J. Surg. 1994. — Vol. 81. — P. 1642−1646.
- Aliberti C, Tilli M, Benea G, Fiorentini G Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. Anticancer Res (2006) 26:3793−3795
- Aliberti C, Benea G, Tilli M, Fiorentini G, Chemoembolization (TACE) of Unresectable Intrahepatic Cholangiocarcinoma with Slow-Release Doxorubicin-Eluting Beads: Preliminary Results. Cardiovasc Intervent Radiol 2008−31:883−888.
- Alsowmely AM, Hodgson HJ. Non-surgical treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 2002- 16: 1−15.
- Aoyama T, Mastrangelo MJ, Berd D, et al. Protracted survival after resection of metastatic uveal melanoma. Cancer 2000- 89:1561−1568.
- Atiq ОТ, Kemeny N, Niedzwiecki D, Botet J. Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin С through an implantable pump. Cancer 1992−69:920−924
- Barber FD, Mavligit G, Kurzrock R. Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview. Cancer Treat Rev 2004- 30:425−36
- Barletta E., Fiore F., D’Angelo R., et al. Intra-frterial second line chemotherapy with 5-Fluorouracil, leucovorin, doxorubicin and carboplatin
- FLEC) for advanced adenocarcinoma of the pancreas// Ann. 0ncol.-2001.-Suppl.4 P. 97.
- Bedikian AY, Legha SS, Mavligit G, et al. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer 1995−76:1665−1670.
- Benson AB Ш, Mitchell E, Abramson N, et al. Oral eniluracil/ 5-fluorouracil in patients with inoperable hepatocellular carcinoma. Ann Oncol 2002−13:576−581.
- Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, Majno P, Engerran L. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996−224:509−520.
- Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, Roche A Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992−163:387−394.
- Blaker H, Hofmann W. J, Theuer D, et al. Pathohistologische Befunde bei Lebermetastasen. Radiologe 2001−41:1−7.
- Bloomston M, Al-Saif O, Klemanski D et al. Hepatic Artery Chemoembolization in 122 Patients with Metastatic Carcinoid Tumor: Lessons Learned J Gastrointest Surg 2007- 11:264−271.
- Bold R.J., Charnsangavej C., Karen R.C. et al. Major vascular resection as part of pancreatoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis // J. Gastrointestinal Surg. 1999. — Vol. 3. — № 3. — P. 233−243.
- Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954- 30: 969−977.
- Brennan M.F., Moccia R.D., Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. // Ann Surg. 1996- 223:506−512.
- Brown DB, Pilgram TK, Darcy MD, Fundakowski CE, Lisker-Melman M, Chapman WC, Crippin JS Hepatic arterial chemoembolization forhepatocellular carcinoma: Comparison of survival rates with different embolic agents. J Vase Interv Radiol 2005−16:1661−1666.
- Brown BD, Geschwind JF, Soulen MC, et al. Society of interventional radiology position statement on chemoembolization of hepatic malignancies. J Vase Interv Radiol 2006−17:217−223.
- Bruix J, Llovet JM, Castells A, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution. Hepatology 1998−27:1578−1583.
- Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Christensen E, Burroughs A, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001−35:421−430.
- Buell JF, Rosen S, Yoshida A, et al. Hepatic resection: Effective treatment for primary and secondary tumors. Surgery 2000−128:686−693.
- Cantore M., Pederzoli P., Cornalba G. et al. Intraarterial chemotherapy for unresectable pancreatic cancer // Ann. Oncol. 2000. — Vol. 11:569−573.
- Carr BI, Flickinger JC, Lotze MT: Hepatobiliary cancers, in Cancer. Principles and practice of oncology: eds DeVita VT, Hellmann S, Rosenberg SA- Lippincott-Raven Publishers 1997 pp 1087−1114.
- Castells A, Bruix J, Ayuso C, Bru C, Montanya X, Boix L, Rodes J Transarterial embolization for hepatocellular carcinoma: Antibiotic prophylaxis and clinical meaning of postembolization fever. J Hepatol 1995−22:410−415.
- Chan AO, Yuen MF, Hui CK, Tso WK, Lai CL A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 2002−94:1747−1752.
- Chung JW Transcatheter arterial chemoembolization of hepatocellular carcinoma. Hepatogastroenterology 1998−45Suppl 3.: 1236−1241.
- Chung JW- Park JH- Han Ж- Choi BI- Han MC- Lee HS- Kim CY Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization see comments., Radiology 1996 Jan-198(l):33−40.
- Chung JW, Park JH, Im JG, et al. Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1993−187:689−693.
- Cohen AD, Kemeny NE An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist 2003−8(6):553—566.
- Coldwell DM, Stokes KR, Yakes WF Embolotherapy: Agents, clinical applications, and techniques. Radiographics 1994−14:623−643.
- Cormier JN, Thomas KT,. Chari RS et al. Management of Hepatocellular Carcinoma Journal of Gastrointestinal Surgery, 2006: Vol. 10, No. 5:761−780.
- Curley SA, Izzo F, Gallipoli A, de Bellis M, Cremona F, Parisi V. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann Surg 1995−222:375−380.
- De Brauw LM, van de Velde CJ, Bouwhuis-Hoogerwerf ML, Zwaveling A. Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases. J Surg Oncol 1987−34:81−86.
- De Caprio J.A., Mayer R.J., Gonin R. et al. Fluorouracil and highdose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial // J. Clin. Oncol. — 1991. — Vol. 9. — P. 2128−2133.
- Di Bisceglie AM. Epidemiology and clinical presentation of hepatocellular carcinoma. J Vase Interv Radiol 2002−13:169−171.
- Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 1991−78:797−801.
- Doppman JL, Dunnick NR, Girton M, Fauci AS, Popovsky MA Bile duct cysts secondary to liver infarcts: Report of a case and experimental production by small vessel hepatic artery occlusion. Radiology 1979−130:1−5.
- Drougas JG, Lowell BA, Blair TK, Lopez RR, Wright Ж, Chapman WC, Webb L, Mazer M, Meranze S, Pinson CW. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Am J Surg 1998−175:408−412.
- Eddie K. Abdalla, Rene Adam, Anton J. Bilchik et el. Improving Respectability of Hepatic Colorectal Metastases: Expert Consensus Statement. Ann. Surg. Oncol. 2006−13(10):1271−1280.
- Elias D, Sideris L, Pocard M, Ouellet JF, Boige V, Lasser P, Pignon JP, Ducreux M. Results of R0 resection for colorectal liver metastases associated with extrahepatic disease. Ann Surg Oncol 2004- 11: 274−280.
- El-Serag HB Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002−35(Suppl):72−78.
- Ensminger W.D., Gyves J.W., Stetson P., Walker-Andrews S. Phase I Study of Hepatic Arterial Degradable Starch Microspheres and Mitomycin Cancer Res. 1985 Sep-45(9):4464−4467.
- Eyol E, Boleij A, Taylor RR, Lewis AL, Berger MR. Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin. Clin Exp Metastasis. 2008−25(3):273−82.
- Fan J, Wu ZQ, Tang ZY, Zhou J, Qiu SJ, Ma ZC, Zhou XD, Ye SL Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein. World J Gastroenterol 2001−7:28−32.
- Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999−230:309−318- discussion 318−321.
- Franco D, Capussotti L, Smadja C, et al. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology 1990−98:733−738.
- Gates J, Hartnell GG, Stuart KE, Clouse ME Chemoembolization of hepatic neoplasms: Safety, complications, and when to worry. Radiographics 1999- 19:399−414.
- Georgiades C.S., Geschwind J-F., Vascular Embolotherapy, Chemo-Embolization for Liver 2006-Vol.2:129−140.
- Georgiades CS, Hong K, D Angelo M, Geschwind JF Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vase Interv Radiol 2005−16:1653— 1659.
- Geschwind J-F. Chemoembolization for hepatocellular carcinoma: Where does the truth lie? J Vase Interv Radiol 2002−13:991−994.
- Glimelius В., Hoffman K., Sjoden P. et al. Chemotherapy improves survival and quality of life in advanced pancreatic cancer and biliary cancer // Ann. Oncol. 1996. — Vol. 7. — P. 593−600.,
- Gragoudas ES, Egan KM, Seddon JM, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991- 98:383—389.
- Guan YS, Zheng XH, Zhou XP et al. Multidetector CT evaluation of hepatocellular carcinoma, World J Gastroenterol 2004−10(14):2127−2129.
- Gupta S, Johnson MM, Murthy R Hepatic Arterial Embolization and Chemoembolization for the Treatment of Patients with Metastatic Neuroendocrine Tumors Variables Affecting Response Rates and Survival Cancer, October 15, 2005−104 (8):1590−1602.
- Gupta S, Bent S, Kohlwes J. Test characteristics of alphafetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 2003- 139:46−50.
- Heinemann V., Quietzsch D., Gieseler F. et al. A phase 1П trial comparing gemcitabine plus cisplatin vs gemcitabine alone in pancreatic carcinoma // Proc. ASCO. -2003. Vol. 22. abstr. 1003.
- Herber S, Otto G, Schneider J, Manzl N, Kummer I, Kanzler S, Schuchmann A, Thies J, Du’ber C, Pitton M Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma. CardioVasc Interv Radiol 2007−30(6):1156−1165.
- Higashihara H, Okazaki M Transcatheter arterial chemoembolization of hepatocellular carcinoma: a Japanese experience. Hepatogastroenterology 2002−49:72−78.
- Hocher H., Green M.D., Speyer J.L. et al. Activity of epirubicin in pancreatic carcinoma // Cane. Treat. Rep. — 1986. — Vol. 70. — P. 299−300.
- Holt DR, Thiel DV, Edelstein JJ. Hepatic resections. Arch Surg 2000- 135: 1353−1358.
- Homma H., Doi Т., Mezawa S. et al. A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization Cancer. —2000. — Vol.89. — 303−313.
- Huang SF, Ко CW, Chang CS, Chen GH. Liver abscess formation after transarterial chemoembolization for malignant hepatic tumor. Hepatogastroenterology. 2003 Jul-Aug-50(52):l 115−8.
- Huo TI, Wu JC, Lee PC, Chang FY, Lee SD Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: A prospective study. Liver Int 2004−24:210−215.
- Hwang TL, Chen MF, Lee TY, Chen TJ, Lin DY, Liaw YF Resection of hepatocellular carcinoma after transcatheter arterial embolization: Reevaluation of the advantages and disadvantages of preoperative embolization. Arch Surg 1987−122:756−759.
- Iwamoto S, Sanafuji H, Okuda К Angiographic subsegmentectomy for the treatment of patients with small hepatocellular carcinoma. Cancer 2003- 97:1051−1056.
- Izzo F, Cremona F, Ruffolo F, Palaia R, Parisi V, Curley SA. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. Ann Surg 1998−227:513−518.
- Jaeger HJ, Mehring UM, Castaneda F, Hasse F, Blumhardt G, Loehlein D, Mathias KD Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol 1996- 19:3 88 396.
- Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer J Gastrointest Surg 2007−11:1057−1077.
- Jemal A, Murray T, Ward E, et al., Cancer Statistics 2005, CA Cancer J Clin, 2005−55:10−30.
- Jenkins LT, Millikan KW, Bines SD, Staren ED, Doolas A. Hepatic resection for metastatic colorectal cancer. Am Surg 1997−63:605−610.
- Johnson PJ, Kalayci C, Dobbs N, Raby N, Metivier EM, Summers L, Harper P, Williams R Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: Effect of coadministration of lipiodol. J Hepatol 1991−13:120−127.
- Kajanti M, Pyrhonen S, Mantyla M, Rissanen P. Intra-arterial and intravenous use of 4' epidoxorubicin combined with 5-fluorouracil in primary hepatocellular carcinoma. A randomized comparison. Am J Clin Oncol 1992−15:37−40.
- Kemeny N, Jarnagin W, Paty P, et al. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 2005- 23:4888−96.
- Kew MC. Epidemiology of hepatocellular carcinoma. Toxicology 2002- 181−182:35−38.
- Kokudo N, Imamura H, Sugawara Y, Sakamoto Y, Yamamoto J, Seki M, Makuuchi M. Surgery for multiple hepatic colorectal metastases. J Hepatobiliary Pancreat Surg 2004- 11: 84−91.
- Konno T Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium. Cancer 1990−66:1897−1903.
- Kress O, Wagner HJ, Wied M, Klose KJ, Arnold R, Alfke H Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors a retrospective single-center analysis. Digestion 2003−68 (2−3):94−101.
- Kubicka S, Rudolph KL, Tietze MK, Lorenz M, Manns M. Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Hepatogastroenterology 2001−48: 783−789.
- Lai CL, Wu PC, Chan GC, Lok AS, Lin HJ. Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer 1988−62:479−483.
- Laweus D, Taylor I. Chemotherapy for colorectal cancer an overview of current managements for surgeons. EJSO 2005−31:932−941.
- Leung TK, Lee CM, Chen HC Anatomic and technical skill factor of gastroduodenal complication in post-transarterial embolization for hepatocellular carcinoma: A retrospective study of 280 cases. World J Gastroenterol 2005- 11:1554−1557.
- Lewis AL, Taylor RR, Hall B, Gonzalez MV, Willis SL, Stratford PW. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vase Interv Radiol. 2006 Aug- 17(8): 1335−43.
- Li XP, Meng ZQ, Guo WJ, Li J, Treatment for liver metastases from breast cancer. World J Gastroenterol 2005-ll (24):3782−3787.
- Lin DY, Liaw YF, Lee TY, Lai CM Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma: A randomized controlled trial. Gastroenterology 1988−94:453156.
- Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999−19:329−338.
- Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectablehepatocellular carcinoma: A randomised controlled trial. Lancet 2002−359:1734−1739.
- Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003−37:429−442.
- Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002−35:1164−1171.
- Lopez RR Jr., Pan SH, Hoffman AL, et al. Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma. Arch Surg 2002−137:653−657.
- Lorenz M., Heinrich S., StaibcSebler E. et al. Regional chemotherapy in the treatment of advanced pancreatic cancer — is it relevant? Europ. J. Cancer. 2000−36:957−965.
- Lorenz M, Petrowsky H, Heinrich S, Janshon G, Staib-Sebler E, Poloczek Y, Gog C, Oremek G, Encke A. Isolated hypoxic perfusion with mitomycin С in patients with advanced pancreatic cancer Eur J Surg Oncol. 1998 Dec-24(6):542−7.
- Lygiadakis N.J., Sgourakis G., Georgia D. Et al. Regional targeting chemoimmunotherapy in patients undergoing pancreatic resection in an advanced stage of their disease: a prospective randomized study// Ann. Surg. — 2002−236(6):806−813.
- Macdonald J. Seminars in Oncology // Pancriatic cancer. 1996. — Vol. 23, N2.-P. 279.
- Makuuchi M, Sukigara M, Mori T, Kobayashi J, Yamazaki S, Hasegawa H, Moriyama N, Takayasu K, Hirohashi S Bile duct necrosis: Complication of transcatheter hepatic arterial embolization. Radiology 1985−156:331−334.
- Malagari K, Chatzimichael K, Alexopoulou E, et al. Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma with Drug Eluting Beads: Results of an Open-Label Study of 62 Patients Cardiovasc Intervent Radiol 2008−31:269−280.
- Marelli L, Stigliano R, Triantos Ch et al., Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies Cardiovasc Intervent Radiol 2007- 30:6−25.
- Matsui O, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Demachi H Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: Local therapeutic effect and 5-year survival rate. Cancer Chemother Pharmacol 1994−33Suppl.:84−88.
- Matsuo N, Uchida H, Nishimine K, et al. Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue. J Vase Interv Radiol 1993- 4:543−549.
- Matsuo N, Uchida H, Sakaguchi H, et al. Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: Studybased on lipiodol accumulation patterns and histopathologic findings. Semin Oncol 1997−24Suppl 6.:S61−70.
- McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990−108:1091−1096.
- Mehta V., Fisher G., Ford J. et al. Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancriatic cancer // Int. J. Rad. Oncol. Biol. Phys. 2000. — Vol. 48. — P. 1483−1487.s
- Mehta V., Fisher G., Ford J. et al. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas // J. Gastrointest. Surg. — 2001.-Vol. 5.-P. 27−35
- Melichar B, Cerman J Jr, Dvorak J, Jandik P, Mergancova J, Melicharova K, Touskova M, Krajina A, Voboril Z. Regional chemotherapy in biliary tract cancers a single institution experience. Hepatogastroenterology 2002−49:900−906.
- Michelassi F., Erroi F., Dawson P.J. et al. Experience with 647 concecutive tumors of duodenum, ampulla, head of pancreas and common bile duct // Ann. Surg. 1989. — Vol. 210. — P. 544−556.
- Miraglia R., Pietrosi G., Maruzzelli L., Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma World J Gastroenterol 2007 June 7- 13(21): 29 522 955.
- Miyayama S, Matsui O, Taki K, et al. Extrahepatic Blood Supply to Hepatocellular Carcinoma: Angiographic Demonstration and Transcatheter Arterial Chemoembolization Cardiovasc Intervent Radiol 2006−29:39−48.
- Moertel C.G., Schutt A., Reitemeier RJ. et al. Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination // Cane. Treat. Rep. 1976. — Vol. 60. — P. 729−732.
- Montalto G, Cervello M, Giannitrapani L et al. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann NY Acad Sci 2002−963:13−20.
- Morante A, Romano M, Cuomo A, de S, I, Cozzolino A, Mucherino C, Salerno R, Blanco С, V, Romano M Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma. Gastrointest Endosc 2006−63:718−720.
- Nagasue N, Uchida M, Makino G et al: Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993- 105: 488−494.
- Nakamura H, Tanaka T, Hori S, Yoshioka H, Kuroda C, Okamura J, Sakurai M Transcatheter embolization of hepatocellular carcinoma: Assessment of efficacy in cases of resection following embolization. Radiology 1983−147:401−405
- Nakao A., Harada A., Nonami T. et al. Clinical significance of portal invasion by pancreatic head carcinoma // Surgery — 1995. — Vol. 117. N1. — P. 50−55.
- Nakao N, Uchida H, Kamino K, et al. Determination of the optimum dose level of Lipiodol in transcatheter arterial embolization of primary hepatocellularcarcinoma based on retrospective multivariate analysis. CardioVasc Interv Radiol 1994−17:76−80.
- Neoptolemas J.P., Cunningham D., Friess H. et al. Adjuvant therapy in pancreatic cancer: Histological and current perspectives // Ann. Oncol. — 2003. -Vol. 14.-P. 675−692.
- Ohishi H, Uchida H, Yoshimura H, et al. Hepatocellular carcinoma detected by iodized oil. Radiology 1985−154:25−29.
- Okuda K. Primary liver cancer in Japan. Cancer 1980−45: 2663−2672.
- Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, Ohnishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985- 56: 918 928.
- Otto G., Diagnostic and surgical approaches in hilar cholangiocarcinoma Int J Colorectal Dis 2007−22: 101−108.
- Palmer K.R., Kerr M., Knowles G. et al. Chemotherapy prolongs survival in inoperable pancreatic carcinoma // Brit. J. Surg. 1994. — Vol. 81. — 882 p.
- Park SH, Cho YK, Ahn Y-S, et al. Local Recurrence of Hepatocellular Carcinoma after Segmental Transarterial Chemoembolization: Risk Estimates Based on Multiple Prognostic Factors, Korean J Radiol 2007−8:111−119
- Patel K, Sullivan K, Berd D, et al. Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study. Melanoma Res 2005−15:297−304.
- Patt YZ, Yoffe B, Charnsangavej C, et al. Low serum alphafetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b. Cancer 1993−72:2574−2582.
- Pawarode A, Voravud N, Sriuranpong V et al: Natural history of untreated primary hepatocellular carcinoma: A retrospective study of 157 patients. Am J Clin Oncol 1998−21: 386−391.
- Pawarode A. et al., 1998, Singh AD, Borden EC. Metastatic uveal melanoma. Ophthalmol Clin North Am 2005- 18:143−150
- Pawlik TM, Choti MA, Surgical Therapy for Colorectal Metastases to the Liver J Gastrointest Surg 2007- 11:1057−1077.
- Pawlik TM, Scoggins CR, Thomas MB, Vauthey JN Advances in the surgical management of liver malignancies. Cancer J 2004−10(2):74—87.
- Paye F, Farges O, Dahmane M, Vilgrain V, Flejou JF, Belghiti J Cytolysis following chemoembolization for hepatocellular carcinoma. Br J Surg 1999- 86:176−180.
- Pazdur R., Ajani J.J., Abbuzzese J.L. et al. Phase П evaluation of fluorouracil and recombinant a-interferon in previously untreated patients with pancreatic adenocarcinoma // Cancer. — 1992. Vol. 70. — P. 2073−2076.
- Pentecost MJ, Daniels JR, Teitelbaum GP, Stanley P Hepatic chemoembolization: Safety with portal vein thrombosis. J Vase Interv Radiol 1993−4:347−351.
- Petrowsky H, Heinrich S, Staib-Sebler E, Gog C, Janshon G, Lorenz M. Isolated hypoxic perfusion with mitomycin С confers no benefit for patients with advanced pancreatic carcinoma Langenbecks Arch Chir Suppl Kongressbd. 1998−115:1351−3.
- Pickren JW, Tsukada Y, Lane WW (1982) Liver metastasis. In: Weiss L, Gilbert HA (eds) Analysis of autopsy data. GK Hall, Boston, pp 2−18.
- Pocard M, Pouillart P, Asselain B, Salmon R. Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol 2000−26: 155 159.
- Rao S., Cunningham D. Advanced pancreatic cancer 5 years on // Ann. Oncol.-2002−13 (8):1165−1168.
- Roche A, Girish BV, de Baere T, Baudin E, Boige V, Elias D, Lasser P, Schlumberger M, Ducreux M. Transcatheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 2003−13(1): 136−140.
- Sakamoto E, Hasegawa H, Ogiso S, Igami T, Mori T, Mizuno T, Hattori K, Sugimoto M, Fukami Y. Curative resection for a pancreatic endocrine carcinoma involving the portal vein. //Hepatogastroenterology. 2004 Nov-Dec. — 51(60): 1849−1851.
- Sakamoto N, Monzawa Sh, Nagano H, Nishizaki H, Arai Ya, Sugimura K. Acute Tumor Lysis Syndrome Caused by Transcatheter Oily Chemoembolization in a Patient with a Large Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 2007−30:508−511.
- Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, f
- Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL, Miller LL. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000−343:905−914.
- Saltz LB, Meropol NJ, Loehrer PJ, Sr., Needle MN, Kopit J, Mayer RJ. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol 2004−22:1201— 1208.
- Sangro B, Rios R, Bilbao I, et al. Efficacy and toxicity of intra-arterial cisplatin and etoposide for advanced hepatocellular carcinoma. Oncology 2002−62:293−298.
- Satake M., Uchida H, Arai Y, et al. Transcatheter Arterial Chemoembolization (TACE) with Lipiodol to Treat Hepatocellular Carcinoma: Survey Results from the TACE Study Group of Japan Cardiovasc Intervent Radiol 2008−31:756−761.
- Sasson AR, Sigurdson ER Surgical treatment of liver metastases. Semin Oncol 2002−29(2):107—118.
- Scheithauer W., Pfeffel F., Komek G. et al. A phase II trial of PALA in combination with 5fluorouracil, leucovorin and recombinant alpha2b interferon in advanced adenocarcinoma of the pancreas // Cancer. 1992. -Vol. 70.-P. 1864−1866.
- Schell SR, Camp ER, Caridi JG, Hawkins IF (2002) Hepatic arteiy embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors. J Gastrointest Surg 6(5):664−670
- Schnall S., Macdonalds J.S. Chemotherapy of adenocarcinoma of the pancreas // Sem. Oncol. 1996. — Vol. 23(2):22−28.
- Sharma KV, Gould JE, Harbour JW et al. Hepatic Arterial Chemoembolization for Management of Metastatic Melanoma, Am J Roentgenol. 2008 Jan-190(l):99−104.
- Shiah HS, Liu TW, Chen LT, Chang JY, Liu JM, Chuang TR, Lee WS, Whang-Peng J. Pulmonary embolism after transcatheter arterial chemoembolization. Eur J Cancer Care (Engl). 2005 Dec-14(5):440−442.
- Shields JA, Shields CL, De Potter P, Singh AD. Diagnosis and treatment of uveal melanoma. Semin Oncol 1996−23:763−767.
- Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973−1997. Ophthalmology 2003−110:956−961.
- Singh AD, Borden EC. Metastatic uveal melanoma. Ophthalmol Clin North Am 2005−18:143−150.
- Snady H., Bruckner H., Cooperman A. et al. Survival advantage of combined chemoradiotherapy compared with resection as the initial trearment of patients with regional pancreatic carcinoma. An outcomes trial // Cancer. — 2000-Vol. 89:314−327.
- Solcia E., Capella C., Kloppel G. Atlas of tumor pathology. Third series. Fascicle 20. Tumors of the pancreas. Bethesda, Maryland, 1997. — P. 25−28.
- Song SY, Chung JW, Han JK, Lim HG, Koh YH, Park JH, Lee HS, Kim CY. Liver abscess after transcatheter oily chemoembolization for hepatictumors: incidence, predisposing factors, and clinical outcome. J Vase Interv Radiol. 2001 Mar- 12(3):313−320.
- Soulen MC. Chemoembolization of hepatic malignancies. Oncology (Williston Park) 1994−8:77−84.
- Strosberg JR, Choi J, Cantor AB, Kvols LK. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors. Cancer Control. 2006 Jan-13(l):72−78.
- Tajima T, Honda H, Kuroiwa T, et al. Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer. J Vase Interv Radiol 2002−13:893−900.
- Takao H, Makita K, Doi I, et al. Cerebral lipiodol embolism after transcatheter arterial chemoembolization of hepatocellular carcinoma. J Comput Assist Tomogr 2005−29(5):680−682.
- Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, Hasegawa H, Hirohashi S Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 1987−163:345−351.
- Takenaka K, Yoshida K, Nishizaki T, Korenaga D, Hiroshige K, Ikeda T, Sugimachi К Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg 1995−169:400−404.
- Tanaka .N, Yamakado K, Nakatsuka A, Fujii A, Matsumura K, Takeda K, Arterial chemoinfusion therapy through an implanted port system for patients with unresectable intrahepatic cholangiocarcinoma-initial experience. Eur J Radiol 2002−41:42−48.
- Tang ZY, Yu YQ, Zhou XD, et al. Surgery of small hepatocellular carcinoma. Analysis of 144 cases. Cancer 1989−64:536−541.
- Tarazov PG Transcatheter therapy of gastric cancer metastatic to the liver: preliminary results. J Gastroenterol 2000−35(12):949−950.
- Tarazov PG, Polysalov VN, Prozorovskij KV, Grishchenkova IV, Rozengauz EV Ischemic complications of transcatheter arterial chemoembolization in liver malignancies. Acta Radiol 2000−41:156−160.
- Tazawa J, Maeda M Radiation therapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. Nippon Rinsho 2001- 59[Suppl 6]: 743−747.
- Tellez C, Benson AB III, Lyster MT, et al. Phase II trial of chemoembolization for the treatment of metastatic colorectalcarcinoma to the liver and review of the literature. Cancer 1998- 82:1250−1259.
- Toyoda H, Nakano S, Kumada T, et al. The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma. Oncology 1995−52:295−299.
- Tsuzuki T, Sugioka A, Ueda M, et al. Hepatic resection for hepatocellular carcinoma. Surgery 1990−107:511−520.
- Uchida H, Matsuo N, Nishimine K, et al. Transcatheter arterial embolization for hepatoma with Lipiodol. Hepatic arterial and segmental use. Semin Interv Radiol 1993−10:19−26.
- Van Wegensveld B.A., Coene P., van Gulik F. et al. Outcome of palliative biliary and gastric bypass for pancreatic head carcinoma in 126 patients // Brit J. Surg. 1997−84 (10):1402−1406.
- Varker KA, Martin EW, Klemanski D, Repeat Transarterial Chemoembolization (TACE) for Progressive Hepatic Carcinoid Metastases Provides Results Similar to First TACE, J Gastrointest Surg. 2007 Dec-ll (12):1680−1685.
- Vogl TJ, Zangos S, Eichler K, Yakoub D, Nabil M. Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization
- TACE) and hepatic chemoperfiision: an update. Eur Radiol 2007−17: 10 251 034.
- Vogl TJ, Mack MG, Balzer JO, Engelmann K, Straub R, Eichler K, Woitaschek D, Zangos S. Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy. Radiology 2003−229: 457−464.
- Wallace S, Carrasco CH, Charnsangavej C, Richli WR, Wright K, Gianturco C. Hepatic artery infusion and chemoembolization in the management of liver metastases. Cardiovasc Intervent Radiol 1990−13:153−160.
- Wanebo H., Vezeridis M. Pancreatic carcinoma in perspective. A continning challenge // Cancer. 1996−78(3):580−591.
- Wigmore SJ, Redhead DN, Thomson BN, Currie EJ, Parks RW, Madhavan KK, Garden OJ Postchemoembolisation syndrome: tumour necrosis or hepatocyte injury?. Br J Cancer 2003−89:1423−1427.
- Wils J., Bleiberg H., Blijham G. et al. Phase II study of epirubicin in advanced adenocarcinoma of the pancreas // Europ. J. Cane. Clin. Oncol. — 1985−21:191−194.
- Wolf DC. Screening for hepatocellular carcinoma: Is it cost-effective? Liver Transpl 2003−9:682−683.
- Wu RH, Tzeng WS, Chang CM Iodized oil embolization to brain following transcatheter arterial embolization of liver. J Gastroenterol Hepatol 2005- 20:1465−1467.
- Wu M, Chen H, Yao X. Surgical treatment of primary liver cancer, in Chinese. Zhonghua Wai Ke Za Zhi 1996−34:707−710.
- Yamanaka N, Okamoto E, Toyosaka A, et al/Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer 1990−65:1104−1110.
- Yang TS, Lin YC, Chen JS, Wang HM, Wang CH. Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma. Cancer 2000−89:750−756.
- Yip D., Halford S., Karapetis C. et al. A phase II trial of caelyx in the treatment of advanced pancreatic carcinoma // Proc. ASCO. 1999. — 1177 p.,
- Yoo KM, Yoo BG, Kim KS, Lee SU, Han ВН. Cerebral lipiodol embolism during transcatheter arterial chemoembolization. Neurology. 2004 Jul 13−63(l):181−3
- Zimmermann H, Reichen J, Hepatectomy: Preoperative analysis of hepatic function and postoperative liver failure — a review, Digest. Surg. 1998−15, 1: 111.